An Institute of Medicine advisory committee has issued recommendations for 100 areas that should receive priority attention with comparative-effectiveness research. The report, Initial National Priorities for Comparative Effectiveness Research, comes one day after the 15-member Federal Coordinating Council for Comparative Effectiveness issued its recommendations for comparative-effectiveness priorities.
In addition to clinical research priorities, the IOM advisory committees report also identified steps that Congress and federal agencies should take to ensure ongoing support of a robust and sustainable comparative-effectiveness research program, according to a news release. The recommendations are part of an early effort to direct spending of $1.1 billion that the American Recovery and Reinvestment Act set aside for developing a national program for comparing the success of various disease treatment and prevention approaches.
The IOM committees research priorities include funding studies that compare treatment strategies for atrial fibrillation; the effectiveness of primary prevention methods vs. clinical treatment; and the success of comprehensive care programs such as medical homes. Committee members also said lawmakers should help ensure long-term success of a comparative-effectiveness program by supporting the establishment of accessible, large-scale clinical and administration data networks; expanding the comparative-effectiveness research workforce through training opportunities; and promoting effective distribution and clinical adoption of study findings.